Navigation Links
Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
Date:1/9/2008

RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Kelly McKee, M.D., as Executive Director of Operations for the company's Public Health and Government Services unit. McKee brings tremendous experience and expertise in infectious diseases and vaccine product development. He will report to Oren Cohen, M.D., Quintiles' Chief Medical and Scientific Officer, and Head of the Public Health and Government Services unit.

"Kelly will play an important alliance management role with government and commercial sponsors as well as Quintiles internal resources," Cohen said. "Our team is resourced and committed to assisting pharmaceutical and biotech companies win government contracts to advance public health."

Prior to his appointment as Executive Director of Operations, McKee served as Senior Director, Medical and Scientific Services (Infectious Diseases) for Quintiles where he was responsible for providing medical support to investigative sites. Previously, he served as Senior Director for Clinical Research for DynPort Vaccine Company where he directed clinical trials.

McKee earned his medical degree from the University of Virginia School of Medicine and completed his internship, residency and fellowship training in pediatrics and pediatric infectious diseases at Vanderbilt University Hospital. He completed a 20-year career in the U.S. Army Medical Department, during which he completed residency training in Preventive Medicine at the Walter Reed Army Institute of Research. McKee also earned a Master's degree in Public Health from Johns Hopkins University School of Hygiene and Public Health.

About Quintiles Public Health and Government Services

Quintiles Public Health and Government Services has the expertise and experience to develop products that improve global public health and enhance readiness to respond to bioterrorism threats, through its partnerships with governments, non-governmental organizations (NGOs) and the biopharmaceutical industry.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the biotechnology and healthcare industries. With about 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.quintiles.com.


'/>"/>
SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Expert Cardiologist Joins Quintiles Medical Group
3. KGI Names Kerry Howell Vice President for Advancement
4. Vical Names Andrew de Guttadauro Vice President, Corporate Development
5. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
6. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
7. CryoLife Names Philip Theodore as Vice President, General Counsel
8. Genstar Names Michael Hurt to Its Strategic Advisory Board
9. PPD Names Daniel Darazsdi as Chief Financial Officer
10. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
11. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016 The Department of ... awarded the 44 million US Dollar project, for the ... Plates including Personalization, Enrolment, and IT Infrastructure , ... the production and implementation of Identity Management Solutions. Numerous renowned ... Decatur was selected for the most ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
Breaking Biology News(10 mins):